Life Scientist > Molecular Biology

Switching off the protein that triggers muscular dystrophy

09 October, 2023

SMCHD1, a gene discovered by researchers in 2008, is critical for switching off the production of the protein that causes facioscapulohumeral muscular dystrophy.


High testosterone levels increase endometrial cancer risk

29 September, 2023

The hormone testosterone may play an important role in the development of endometrial cancer, raising new possibilities for screening, preventing and fighting the disease.


Milestone as RNA recovered from Tasmanian tiger specimen

21 September, 2023

Researchers have isolated and sequenced RNA molecules from a preserved thylacine specimen, resulting in the reconstruction of skin and skeletal muscle transcriptomes from an extinct species.


Target found for gastric cancer associated with EBV

19 September, 2023

Scientists say they have identified a self-destruct button within EBV-associated gastric cancer, and also figured out how to press that self-destruct button.


Largest ever genetic study of epilepsy provides new insights

18 September, 2023

The study has discovered specific changes in our DNA that increase the risk of developing epilepsy, advancing our knowledge of why epilepsy develops.


COVID causes mitochondrial dysfunction in multiple organs

11 September, 2023

The genes of the mitochondria, the energy producers of our cells, can be negatively impacted by SARS-CoV-2, leading to dysfunction in multiple organs beyond the lungs.


Why do tans appear only after we've left the beach?

01 September, 2023

The mechanism that repairs our skin cells' DNA takes precedence over all other systems in the cell, temporarily inhibiting the pigmentation mechanism.


Genetic risk factors found for long COVID

16 August, 2023

Computational biology company PrecisionLife has identified 73 genes that are highly associated with severe and fatigue-dominant forms of long COVID.


In vivo gene editing model developed for blood disorders

07 August, 2023

Researchers developed a proof-of-concept model for delivering gene editing tools to treat blood disorders, allowing for the modification of diseased blood cells directly within the body.


National genomics initiative offers hope to cancer patients

03 August, 2023

The PrOSPeCT program will give 23,000 cancer patients free access to genomic profiling and matching to the best advanced precision treatments available locally, including early-stage clinical trials.


p38 protein inhibitor could help treat heart damage

28 July, 2023

The p38 protein regulates a wide variety of cellular functions and is related to diseases such as chronic inflammation, immunological disorders and cancer.


Scientists find an array of protein folds unexplored in nature

19 July, 2023

Researchers have unveiled an astounding array of unexplored protein folds, expanding our understanding and uncovering the depth of the protein universe.


MGI promises to take genomics to the next level at XXIIIrd International Congress of Genetics

17 July, 2023

MGI promised to take genomics to the next level with its extensive product portfolio and one-stop-shop solutions at the XXIIIrd International Congress of Genetics.


Precise DNA sequencing method may lead to easier testing

11 July, 2023

Researchers have invented a new way to map specific DNA markings called 5-methylcytosine (5mC), which regulate gene expression and have key roles in health and disease.


Rare genetic syndrome identified in children

23 June, 2023

A research team has identified a new rare genetic syndrome that causes intellectual disability and differences of sex development (DSD) in children.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd